A kit for amplifying the full-length sequence of TCR and its application
A nested PCR method using nanoscale microwell chips and specific primers was developed to achieve efficient amplification of the full-length TCRα/β paired sequence at the single-cell level. This method solves the problems of low throughput and insufficient coverage in the existing TCR full-length amplification techniques and is suitable for high-throughput T cell analysis and disease diagnosis.
Patent Information
- Application Number
- CN201780095486.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2017-09-28
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2037-09-28
AI Technical Summary
Existing technologies cannot achieve full-length amplification of TCRα/β paired sequences at the single-cell level, nor can they cover all TRA and TRB subtypes, thus limiting the analysis and application of T cell heterogeneity and different cell subpopulations.
Using nanoscale microwell chips as reaction containers, combined with specific primer design and nested PCR methods, high-throughput amplification of full-length TCR sequences was achieved. This included designing sequencing adapter sequences and nested primers, and using nanoscale microwell chips to amplify TCRα/β pairings in single cells.
It increases amplification throughput, enabling the acquisition of thousands of single T cell-level TCRαβ chain pairing full-length sequences at a time, reducing costs and time. It is suitable for high-throughput cellular heterogeneity analysis and disease diagnosis, and supports immunological research and tumor immunotherapy.
Smart Images

Figure CN111344418B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of molecular biology, and relates to a kit for amplifying a full-length TCR sequence and an application thereof, and specifically relates to a kit for amplifying a full-length TCR sequence, a method for amplifying a full-length TCR sequence and an application thereof. Background Art
[0002] T lymphocyte precursors enter the thymus from the bone marrow, undergo positive and negative selection processes, and develop into mature T cells. During this period, T cells acquire functional T cell receptors (TCRs), express surface molecules of mature T cells (CD4 / CD8, etc.), and acquire MHC restriction and self-tolerance. The complex diversity of T cell types is related to TCR rearrangement. In the thymus, the TRB (TCRβ) gene undergoes DJ, VDJ, and VDJC region rearrangement, ultimately producing about 10 8 Different TRB rearranged genes; TRA (TCRα) gene rearranges through VJ and VJC regions, eventually producing about 10 4 Different TRA rearrangement genes. In human peripheral blood, TCR diversity is as high as 10 due to the rearrangement of TRB and TRA. 18 , which determines how the human immune system adapts to changes in the environment.
[0003] At present, one of the main methods for identifying TCR is to sequence the α and β chains. In traditional immunology research, it is difficult to analyze the characteristics of cell heterogeneity and different cell subsets based on the data obtained from population cell sequencing. Previous TCR amplification methods include: 1. Multiplex PCR amplification combined with high-throughput sequencing technology, by designing multiple primers covering all TRA and TRB typing, capturing as complete TRA and TRB subtypes as possible in the population, and high-throughput sequencing reads the TRA and TRB sequences of each subtype; 2. RACE amplification combined with high-throughput sequencing technology, designing primers through constant known sequences in TCR sequences, amplifying TCR gene sequences in the population, and high-throughput sequencing technology reads the TRA and TRB sequences of each subtype; 3. T cell population transcriptome sequencing, bioinformatics assembly TCR technology, etc. These technologies cannot accurately distinguish T cell subsets and TCRα / β pairing relationships through TCR sequencing, and to further understand the mechanism of T cell immune response, it is necessary to more accurately identify the phenotypic differences within and between different T cell subsets. Therefore, TCRα / β pairing analysis based on single cell level is increasingly being used in immunology research.
[0004] The TCR receptor is a heterodimer formed by the TCRα and TCRβ chains. Since the DNA sequence of the TCR gene is rearranged during the formation of T cells, the diversity of T cells is generated. The diversity of T cells plays a huge role in effective immunity. Recently, a variety of high-throughput technologies based on TCR have emerged, such as:
[0005] (1) PairSEQ high-throughput TCR sequencing technology: This technology uses the diversity of T cells. The TCR sequences corresponding to different T cells in different subgroups are different, and the number of subgroups in the sample and the number of T cells in the subgroup are correlated with the corresponding TCRα / β pairing. The strategy of this technology is to randomly select T cells of obvious subgroups in a 96-well plate, separate the mRNA and amplify the first-strand cDNA of the cells in each well, and then add TCR V region and C region primers to amplify the TCR CDR3 region. The sample-specific barcode is connected to the amplification primer, so that the specific DNA barcode binds to the amplification product during amplification, and each sample can be accurately calibrated. After pooling the amplification products of all samples in the 96-well plate, high-throughput sequencing is performed. By reading the TCR sequence information and DNA barcode information at the same time, the source of the well corresponding to the TCR can be determined by the DNA barcode information between different wells. The TCRα / β pairing in each well T cell subgroup needs to be analyzed through subsequent model construction. Through the computer model, the TCRα / βCDR3 region information of single-cell pairing is obtained.
[0006] The characteristic of this technology is that it can initially realize the amplification and analysis of high-throughput single-cell TCR pairing sequences. However, the disadvantages are very obvious. The initial sample processing process is complicated. It is necessary to group the T cells first, spread them on 96-well plates and sequence them in combination with random DNA barcodes. The data simulation trains the TCRα / β pairing information of different T cell subtypes. The sequenced and assembled TRA and TRB have great limitations on the accuracy of subsequent α / β pairing. The characteristic of this technology is that it can initially realize the amplification and analysis of high-throughput single-cell TCR pairing sequences. However, the disadvantages are very obvious. First, the throughput of this technology is relatively low. Since it is carried out in 96-well plates, its throughput and application are limited. Secondly, this technology is still based on the amplification of the CDR3 region, and the amplification of the full-length TCR pairing sequence is not achieved. The full-length sequence is very critical for its application, especially in immunotherapy.
[0007] (2) TraCeR: This technology uses T cell single-cell transcriptome data to capture TCR transcriptome information in single cells through computers, reconstruct full-length TCRα / β pairing sequences, and distinguish functional T cell clones based on TCR sequence differences. Single-cell transcriptome data can reveal transcriptional heterogeneity between cells and the evolutionary process between different cells, thereby inferring obvious T cell subsets. This technology combines single-cell transcriptome data to assemble and obtain complete TCRα / β pairing sequence information while obtaining expression levels, which has high advantages and innovations. However, since this technology also realizes TCRα / β pairing at the single-cell level based on the multiplex PCR method, it can only obtain the CDR3 region of TCR, but not the full-length TCR sequence. Since this technology relies on computer reconstruction software, the diversity and high variability of the TCR sequence itself determine the difficulty of aligning the rearranged sequence. Therefore, the development of appropriate computer software is the bottleneck of this technology for evaluating the integrity and accuracy of the reconstructed TCR sequence, and the accuracy rate is worth considering.
[0008] (3) Single cell V(D)J: This technology is based on droplet microfluidics technology launched by 10Xgenomics in April 2017. It can obtain TCR sequence information of 100-10,000 single immune cells at one time. However, droplet microfluidics-based technology is a good entry point for obtaining high-throughput TCR sequences, but the droplet microfluidics method is used to achieve TCRα / β pairing at the single cell level, but it has the defects of cross-contamination between double-encapsulated single cells, low encapsulation efficiency and high cost.
[0009] Currently, the existing TCR amplification technology mostly stays at the scale of 96-well plates, and there is no mature high-throughput single-cell amplification method. On the one hand, the low throughput makes it difficult to achieve detailed analysis of T cell heterogeneity and different cell subsets. TCRα / β pairing information is also unknown, and there is no suitable method to amplify the full-length sequence of TCR, which limits its application to a certain extent. On the other hand, the recent progress in single-cell TCR full-length amplification sequencing, although it can solve the problem of TCRα / β pairing to a certain extent, most of the sequence information obtained is the single-cell TCR CDR3 region.
[0010] CN 105543064A discloses a digital PCR chip and a method for using the same: the chip comprises a silicon microporous chip, a microfluidic channel for filling samples and an aluminum thermal conductive base. The silicon microporous chip is processed with 20,000 through holes with hydrophilic inner walls and hydrophobic surfaces, which are used to disperse trace nucleic acids or cell solutions, but are not suitable for high-throughput TCR amplification.
[0011] However, there is currently no ideal technology that can achieve full-length amplification of TCRα / β paired sequences at the single-cell level and cover all known TRA and TRB subtypes. Summary of the invention
[0012] In view of the defects in the prior art, the present invention provides a kit for amplifying the full-length TCR sequence and its application, wherein the kit can achieve full-length amplification of TCRα / β pairing sequence at the single-cell level and can cover all known TRA and TRB subtypes.
[0013] On the one hand, the present invention provides a kit for amplifying the full-length sequence of TCR, wherein the kit comprises a nanoliter-scale microwell chip.
[0014] The present invention adopts nanoliter-scale microporous chips as reaction containers, and can perform TCRα / β pairing amplification of up to 5124 single T cells at a time, thereby improving throughput, and can efficiently obtain thousands of full-length TCRαβ chain pairing sequences at the level of single T cells at one time to construct a TCR immune repertoire.
[0015] In the present invention, the nanoliter-scale microporous chip is a microporous chip with a volume of nanoliters. The number of micropores on the nanoliter-scale microporous chip will not affect the present invention, and those skilled in the art can select it according to needs, and no special limitation is made here.
[0016] According to the present invention, the kit also includes a primer pair for amplifying the full-length sequence of TCR.
[0017] According to the present invention, the primer pair for amplifying the full-length sequence of TCR includes an upstream primer and a downstream primer, the upstream primer is a complementary sequence designed according to the sequencing adapter sequence, and the downstream primer is a complementary sequence designed according to the C region of TCR.
[0018] In the present invention, although TCR has a variety of species, its C region sequence homology is good, so the present invention designs the downstream primer according to the C region, and can be designed at any position from the 5' end to the 3' end of the C region, and then by adding a sequencing adapter sequence (TSO) to the 3' end of the TCR, and designing the upstream primer based on it, the complete V(D)J sequence can be obtained through such upstream and downstream primers, thereby obtaining the full length of the TCR.
[0019] In the present invention, the designed primers follow general primer design principles, such as GC content of 40-60%, no secondary hairpin structure, no primer dimer, etc. The primers should be designed at positions without base polymorphism as much as possible.
[0020] According to the present invention, the sequencing adapter sequence is introduced by the template conversion method, wherein the adapter primer can be any fixed-length sequence, and those skilled in the art can design it as needed. The nucleotide sequence of the adapter primer of the present invention is shown in SEQ ID NO.1, and the nucleotide sequence shown in SEQ ID NO.1 is as follows: 5'-AAGCAGTGGTATCAACGCAGAGT-3';
[0021] According to the present invention, the length of the sequencing adapter sequence is 18-35 nt, for example, it can be 18 nt, 19 nt, 20 nt, 21 nt, 22 nt, 23 nt, 24 nt, 25 nt, 26 nt, 27 nt or 28 nt, preferably 28 nt.
[0022] According to the present invention, the nucleotide sequence of the upstream primer is shown in SEQ ID NO.2, and the nucleotide sequence shown in SEQ ID NO.2 is as follows: 5'-AAGCAGTGGTATCAACGCAGAGT-3'.
[0023] According to the present invention, the downstream primers are nested primers. The inventors have found that the nested primers can not only target samples with a small starting amount in the single cells of the present application, but also target such a complex mechanism as TCR. The results after amplification are very accurate. The downstream primers include external primers and / or internal primers.
[0024] According to the present invention, the full-length TCR consists of the full-length TCRα gene and the full-length TCRβ gene or consists of the full-length TCRγ gene and the full-length TCRδ gene;
[0025] According to the present invention, the nucleotide sequences of the external primer and the internal primer of the downstream primer for amplifying the full length of the TCRα gene are shown in SEQ ID NO.3 and SEQ ID NO.4, respectively, and the nucleotide sequences of the primers are as follows:
[0026] External primer (SEQ ID NO. 3): GCAGACAGACTTGTCACTGG;
[0027] Internal primer (SEQ ID NO. 4): GGTACACGGCAGGGTCAGGGTTC;
[0028] According to the present invention, the nucleotide sequences of the external primer and the internal primer of the downstream primer for amplifying the full length of the TCRβ gene are shown in SEQ ID NO.5 and SEQ ID NO.6 respectively;
[0029] The nucleotide sequences of the primers are as follows:
[0030] External primer (SEQ ID NO. 5): TGGTCGGGGAAGAAGCCTGTG;
[0031] Internal primer (SEQ ID NO. 6): TTCTGATGGCTCAAACACAGCGA;
[0032] In a second aspect, the present invention provides a method for amplifying the full-length sequence of TCR, using the kit as described in the first aspect.
[0033] According to the present invention, the method for amplifying the full-length TCR sequence comprises the following steps:
[0034] (1) performing mRNA reverse transcription in the nanoliter microwell chip to obtain a first-strand cDNA;
[0035] (2) using the first-strand cDNA obtained in step (1) as a template, performing PCR amplification;
[0036] (3) Sequencing verification to obtain the full-length amplification product of the TCR.
[0037] According to the present invention, before step (1), the step of single cell separation and lysis is also included, wherein the single cell separation adopts flow cytometry to sort the single cells, and the sorted single cells are dispensed into the micropores of each micropore chip using a sample micro-dispenser, and the single cells are derived from peripheral blood mononuclear cells of peripheral blood.
[0038] In the present invention, the problems of TCR full-length sequencing and TCR α / β pairing can be completely solved from the high-throughput single-cell level. It can not only distinguish the paired αβ sequence information, but also distinguish different single-cell samples, thereby effectively applying the single-tube TCR paired full-length amplification technology to the high-throughput platform to achieve high throughput.
[0039] According to the present invention, the mRNA reverse transcription system in step (1) includes a sequencing adapter sequence. After the mRNA reverse transcription system is prepared, a sample micro-dispenser is used to dispense the system into each micropore of the micropore chip.
[0040] According to the present invention, the final concentration of the sequencing adapter sequence is 0.8-3 μM, for example, it can be 0.8 μM, 0.9 μM, 1 μM, 1.2 μM, 1.3 μM, 1.5 μM, 1.6 μM, 1.8 μM, 2 μM, 2.2 μM, 2.4 μM, 2.5 μM, 2.6 μM, 2.8 μM or 3 μM, preferably 2 μM;
[0041] According to the present invention, the conditions for reverse transcription of mRNA in step (1) are: 38-45°C 85-95min 1-3 cycles; 48-53°C 1-5min, 38-45°C 1-5min, 8-15 cycles; 68-73°C 10-20min 1-3 cycles; stored at 4°C;
[0042] According to the present invention, the conditions for mRNA reverse transcription in step (1) are: 42°C for 90 min per cycle; 50°C for 2 min, 42°C for 2 min, 10 cycles; 70°C for 15 min per cycle; and stored at 4°C.
[0043] According to the present invention, when the downstream primer is a nested primer, the PCR amplification is a nested PCR;
[0044] According to the present invention, the number of nested PCR is 1-3 times, preferably 2 times;
[0045] According to the present invention, the nested PCR specifically comprises:
[0046] (1') using the upstream primer and the external primer as primers and the first-strand cDNA as a template, performing a first round of nested PCR to obtain a first round of amplification products;
[0047] (2') using the upstream primer and the internal primer as primers and the first round amplification product obtained in step (1') as a template, performing a second round of nested PCR to obtain a second round amplification product;
[0048] According to the present invention, the conditions of the first round of nested PCR in step (1') are: 92-98°C for 1-6 min, 1-3 cycles; 95-100°C for 15-25 s, 53-58°C for 10-20 s, 70-75°C for 35-45 s, 35-45 cycles; 70-75°C for 3-8 min, 1-3 cycles; stored at 4°C;
[0049] According to the present invention, the conditions of the first round of nested PCR in step (1') are: 95°C for 3 min, 1 cycle; 98°C for 20 s, 55°C for 15 s, 72°C for 40 s, 40 cycles; 72°C for 5 min, 1 cycle; stored at 4°C;
[0050] According to the present invention, the conditions of the first round of nested PCR in step (2') are: 92-98°C for 1-6 min, 1-3 cycles; 95-100°C for 15-25 s, 53-58°C for 10-20 s, 70-75°C for 35-45 s, 35-45 cycles; 70-75°C for 3-8 min, 1-3 cycles; stored at 4°C;
[0051] According to the present invention, the conditions of the first round of nested PCR in step (2') are: 95°C for 3 min, 1 cycle; 98°C for 20 s, 55°C for 15 s, 72°C for 40 s, 40 cycles; 72°C for 5 min, 1 cycle; stored at 4°C;
[0052] According to the present invention, the sequencing in step (3) is Sanger sequencing and / or Miseq sequencing.
[0053] In a third aspect, the present invention provides use of the kit as described in the first aspect for constructing a TCR library.
[0054] In a fourth aspect, the present invention provides use of the kit as described in the first aspect for preparing drugs for immunological diagnosis, treatment and / or prognosis monitoring of diseases.
[0055] Compared with the prior art, the present invention has the following beneficial effects:
[0056] (1) The present invention uses a nanoliter microporous chip as a reaction container, and can perform TCRα / β pairing amplification of up to 5124 single T cells at a time, which can improve the throughput and efficiently obtain thousands of TCRαβ chain pairing full-length sequences at the level of single T cells at one time to construct a TCR immune repertoire. At the same time, the reagent cost per cell is reduced by about 70%, and the labor cost is also greatly reduced;
[0057] (2) The present invention can simultaneously obtain TCRαβVDJ region sequences of thousands of cell samples with an initial amount of picograms (1-100 pg) and nanograms. The operation is simple and time-saving. The entire process can be completed within 10-12 hours, with complete subtype coverage and low amplification preference.
[0058] (3) The method of the present invention is suitable for high-throughput cell heterogeneity and T cell subtype clustering, exploring new immunological mechanisms, constructing a large-scale full-length TCR immune library, facilitating disease diagnosis and health management, developing neoTCR-T tumor immune cell therapy in combination with tumor neoantigens, conducting tumor immunotherapy, and monitoring the prognosis of cancer or autoimmune diseases, which helps guide doctors' medication and scientific research, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0059] Figure 1 Flow chart of microwell high-throughput single-cell TCRαβ full-length sequence amplification technology;
[0060] FIG2(a) is a graph showing the real-time monitoring curve of qPCR amplification of the product in row 7, column 45 of the microwell chip as the cycle number changes, and FIG2(b) is a graph showing the real-time monitoring curve of qPCR amplification of the product in row 7, column 45 of the microwell chip as the temperature changes;
[0061] Figure 3The microwell amplification product of the chip aspirated by the microstep instrument 2100 test results;
[0062] Figure 4 Electrophoresis results of high-throughput T cell TCR amplification products in microwell chips, where 1-11 represent the electrophoresis detection results of single-cell amplification products in different chip wells, the marker is a 100bp marker, and from bottom to top are 100bp, 200bp, 300bp, 400bp, 500bp (brightest band), 600bp, 700bp, 800bp, 900bp, 1000bp and 1500bp. DETAILED DESCRIPTION
[0063] The present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments. It is to be understood that the specific embodiments described herein are only used to explain the present invention, rather than to limit the present invention. It should also be noted that, for ease of description, only parts related to the present invention, rather than all structures, are shown in the accompanying drawings.
[0064] Example 1 Assembly of the kit
[0065] (1) Primer design: A sequencing adapter sequence was introduced into the 3' end of the first strand of cDNA by using a sequencing adapter sequence through a template conversion method. The sequencing adapter sequence is shown in SEQ ID NO.1. The nucleotide sequence shown in SEQ ID NO.1 is as follows:
[0066] 5'-AAGCAGTGGTATCAACGCAGAGT-3';
[0067] An upstream primer was designed according to the linker sequence, and the upstream primer was shown in SEQ ID NO.2. The nucleotide sequence shown in SEQ ID NO.2 is as follows:
[0068] 5'-AAGCAGTGGTATCAACGCAGAGT-3';
[0069] The downstream primers were designed according to the C region of the TCR gene, and the complete sequences of the C region of the T cell α and β chains were as follows:
[0070] TCRαC region (SEQ ID NO.7):
[0071] ATATCCAGAACCCTGACCCTGCCGTGTACCAGCTGAGAGACTCTAAATCCAGTGACAAGTCTGTCTGCCTATTCACCGATTTTGATTCTCAAACAAATGTGTCACAAAGTAAGGATTCTGATGTGTATATCACAGACAAATGTGTGCTAGACATGAGGTCTATGGACTTCAAGAGCAACAGTGCTGTGGCCTGGAGCAACAAATCTGACTTTGCATGTGCAAACGCCTTCAACAACAGCATTATTCCAGAAGACACCTTCTTCCCCAGCCCAGAAAGTTCCTGTGATGTCAAGCTGGTCGAGAAAAGCTTTGAAACAGATACGAACCTAAACTTTCAAAACCTGTCAGTGATTGGGTTCCGAATCCTCCTCCTGAAAGTGGCCGGGTTTAATCTGCTCATGACGCTGCGGCTGTGGTCCAGCTGA;
[0072] TCRβ C region (SEQ ID NO.8):
[0073] .
[0074] The Miseq sequencing platform was used, and the primers of the Miseq sequencing platform are as follows:
[0075] Since the longest read length of Miseq is currently 300bp / reads, the PE300 sequencing strategy is used, which requires that the library insert length does not exceed 600bp. The 5' UTR sequence + V+D+J region sequence of the TCRαβ chain is just within 600bp, so we set the downstream primer at a position 20 to 30bp from the 5' end of the C region, as shown below:
[0076] Table 1 Human T cell C region primer (downstream) sequence information
[0077]
[0078] (2) Assemble the designed primers with the WaferGen microwell chip and load them into the kit.
[0079] Example 2 TCR sequencing on Miseq sequencing platform
[0080] The method for amplifying the full-length TCR sequence is shown in the flowchart as follows Figure 1As shown, the following steps are included:
[0081] (1) First-strand cDNA synthesis:
[0082] a) Prepare lysate, the lysate formula is shown in the following table:
[0083]
[0084] The prepared lysate was pipetted and mixed, and then dispensed into a clean 384-well plate, dispensed into 24 wells, 14 μL per well, sealed, centrifuged at 2600 rcf, 4°C for 1 min (centrifuge the droplets to the bottom of the tube and remove bubbles), placed the 384-well plate on the MSND sample micro-dispenser, selected the 35 nL 72 sample spray mode, sprayed 35 nL per microwell on the chip, sealed, centrifuged at 2600 rcf, 4°C for 5 min, stored at 4°C, and waited for the cells to be added;
[0085] b) Single cell isolation
[0086] Prepare cell buffer according to the following table:
[0087]
[0088] Prepare the cell buffer in a 0.2 mL nuclease-free PCR tube, pipette and mix, sort 5800 target single cells into the buffer by FACS (flow cytometer), gently pipette and mix, dispense into a clean 384-well plate, dispense into 24 wells, 14 μL per well, seal the plate, place the 384-well plate on an MSND sample micro-dispenser, select the 35 nL72 sample spray mode, spray 35 nL per microwell on the chip, seal the plate, centrifuge at 2600 rcf, 4°C for 5 min, and the cells are distributed in the nanoliter microwells of the chip according to the Poisson distribution rule;
[0089] c) Cell lysis
[0090] The chip was placed in a Biorad chip-specific PCR instrument, incubated at 72°C for 5 minutes, with the hot cover temperature at 75°C. After lysis, it was immediately placed on ice for 1 minute; centrifuged at 2600rcf at 4°C for 5 minutes, and then immediately transferred to ice; after this step, all mRNAs were released from single cells, and the Oligo-dT primers had also bound to the mRNAs;
[0091] d) mRNA reverse transcription
[0092] Prepare the reverse transcription system as follows:
[0093]
[0094] The reverse transcription buffer was prepared in a 1.5 mL nuclease-free PCR tube, pipetted and mixed, and then dispensed into a clean 384-well plate, dispensed into 24 wells, 14 μL per well, sealed, centrifuged at 2600 rcf, 4°C for 1 min (centrifuge the droplets to the bottom of the tube and remove bubbles), the 384-well plate was placed on the MSND sample micro-dispenser, the 35 nL72 sample spray mode was selected, and 35 nL was sprayed into each microwell on the chip, sealed, and centrifuged at 2600 rcf, 4°C for 5 min;
[0095] Place the chip in a Biorad chip-specific PCR instrument and perform reverse transcription reaction under the following conditions (75°C hot cover):
[0096]
[0097] After the first-strand cDNA synthesis of all mRNAs was completed and reverse transcription was completed, centrifugation was performed at 2600 rcf and 4°C for 5 min;
[0098] (2) Specific TCR sequence amplification, using the primers in Example 1:
[0099] a) First round of PCR
[0100] Using the upstream primer and the external primer as primers and the first-strand cDNA as a template, a first round of nested PCR is performed to obtain a first round of amplification products;
[0101] Prepare the PCR system according to the following table:
[0102]
[0103]
[0104] Prepare the cell buffer in a 1.5mL PCR tube, pipette and mix, and dispense into a clean 384-well plate, dispense into 24 wells, 14μL per well, and seal with film. Place the 384-well plate on the MSND sample micro-dispenser, select the 35nL 72 sample spray mode, spray 35nL per microwell on the chip, seal with film, and centrifuge at 2600rcf, 4℃ for 5min;
[0105] On the BIORAD dedicated chip PCR instrument, pre-amplify according to the following conditions:
[0106]
[0107] b) Second round of PCR
[0108] Using the upstream primer and the middle primer as primers and the first round amplification product obtained in step (a) as a template, a second round of nested PCR is performed to obtain a second round amplification product;
[0109] Use a microstep instrument to aspirate the amplified products in the microwells of the chip into a 96-well plate and prepare the PCR system according to the following table:
[0110]
[0111]
[0112] After mixing by pipetting and centrifugation, pre-amplify according to the following conditions:
[0113]
[0114] (3) Electrophoresis detection
[0115] After the nested PCR was completed, 1 μl was taken for Agilent 2100 detection. The test results were as follows: Figure 2(a) , 2(b) and Figure 3 As shown, from Figure 2(a)-2(b) It can be seen that starting from the 26th cycle of PCR, the amplified product increased significantly, and the melting curve in the lower left figure showed a single peak, indicating that the amplified product was relatively single; Figure 3 It can be seen that the fragment distribution detected by agilent2100 shows that there are indeed only a few relatively specific peaks in the well, and the size is consistent with the target fragment size;
[0116] The remaining samples were subjected to PCR electrophoresis detection using 2% agarose gel. 25 μL of the product was added with 3 μL of sample loading buffer and mixed. The electrophoresis was performed at 130 V for 45 min. The target band was cut and recovered. The results were as follows: Figure 4 As shown, the microwell chip well amplification product (the fifth sample) was further amplified using TCR-internal primers and found that the product had good specificity and was around 600 bp, which was consistent with the expected product size, once again confirming that the TCR amplification results in the microwell chip wells were good.
[0117] (4) The recovered product was subjected to TA cloning and Sanger sequencing, and the sequencing results were as follows:
[0118] α chain sequence
[0119] α1: V12-2+J45+C
[0120] AAGCAGTGGTATCAACGCAGAGTACGGGGAAAGCAGATTCTTTTTATGATTTTTAAAGTAGAAATATCCATTCCAGGTGCATTTTTTAAGGGTTTTAAAATTTGAATCCTCAGTGAACCAGGGCAGAGAAGA ATGATGAAATCCTTGAGAGTTTTACTAGTGATCCTGTGGCTTCAGTTGAGCTGGGTTTGGAGCCAACAGAAGGAGGTGGAGCAGAATTCTGGACCCCTCAGTGTTCCAGAGGGAGCCATTGCCTCTCTCAACTGCACTTACAGTGACCGAGTTTCCCAGTCCTTCTTCTGGTACAGACAATATTCTGGGAAAAGCCCTGAGTTGATAATGTCCATATACTCCAATGGTGACAAAGAAGATGGAAGGTTTACAGCACAGCTCAATAAAGCCAGCCAGTATGTTTCTCTGCTCATCAGAGACTCCCAGCCCAGTGATTCAGCCACCTACCTCTGTGCCGTGACTTCGGGAGGTGCTGACGGACTCACCTTTGGCAAAGGGACTCATCTAATCATCCAGCCCT ATATCCAGAACCCTGACCCTGCCGTGTACC .
[0121] β-chain sequence (V27 + J2)
[0122] AAGCAGTGGTATCAACGCAGAGTACGGGAGACCTGTGGGTGTACTGGTACCAACAGAGCCTGGACCAGGGCCTCCAGTTCCTCATTCAGTATTATAATGGAGAAGAGAGAGCAAAAGGAAACATTCTTGAACGATTCTCCGCACAACAGTTCCCTGACTTGCACTCTGAACTAAACCTGAGCTCTCTGGAGCTGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGAGGGAAGGTTTCTTGTCACCCCTCCACTTTGGGAATGGGACCAGGCTCACTGTGA CAGAGGACCTGAACA AGGTGTTCCCACCCGAGGTCGCTGTGTTTGAGCCATCAGAA
[0123] The above results are organized as shown in Table 3 below:
[0124] Table 3
[0125]
[0126] As can be seen from Table 3, the α and β types of the sample are respectively:
[0127] α: V12-2 and J45
[0128] β: V9J1-6.
[0129] It can be seen that using the Sanger sequencing platform, sequencing can directly obtain the TCRαβVDJ region sequence and also achieve TCRα / β pairing.
[0130] In summary, the present invention uses a nanoliter-scale microporous chip as a reaction container, which can perform TCRα / β pairing amplification of up to 5124 single T cells at a time, thereby improving throughput and efficiently obtaining thousands of full-length TCRαβ chain pairing sequences at the level of single T cells at one time to construct a TCR immune repertoire.
[0131] The above are only preferred embodiments of the present invention and the technical principles used. Those skilled in the art will understand that the present invention is not limited to the specific embodiments described herein, and that various obvious changes, readjustments and substitutions can be made by those skilled in the art without departing from the scope of protection of the present invention. Therefore, although the present invention has been described in more detail through the above embodiments, the present invention is not limited to the above embodiments, and may include more other equivalent embodiments without departing from the concept of the present invention, and the scope of the present invention is determined by the scope of the appended claims. Sequence Listing <110> Shenzhen BGI Life Sciences Institute <120> A kit for amplifying the full-length sequence of TCR and its application <130> 2017 <160> 8 <170> PatentIn version 3.3 <210> 1 <211> twenty three <212> DNA <213> Artificial sequence <220> <223> Sequencing adapter sequence <400> 1 aagcagtggt atcaacgcag agt 23 <210> 2 <211> twenty three <212> DNA <213> Artificial sequence <220> <223> Upstream primers for amplifying the full-length TCR sequence <400> 2 aagcagtggt atcaacgcag agt 23 <210> 3 <211> 20 <212> DNA <213> Artificial sequence <220> <223> External primers for downstream primers to amplify the full length of TCRα gene <400> 3 gcagacagac ttgtcactgg 20 <210> 4 <211> twenty three <212> DNA <213> Artificial sequence <220> <223> Internal primers for downstream primers that amplify the full length of the TCRα gene <400> 4 ggtacacggc agggtcaggg ttc 23 <210> 5 <211> twenty one <212> DNA <213> Artificial sequence <220> <223> External primers for downstream primers to amplify the full length of TCRβ gene <400> 5 tggtcgggga agaagcctgt g 21 <210> 6 <211> twenty three <212> DNA <213> Artificial sequence <220> <223> Internal primers for downstream primers to amplify the full length of the TCRβ gene <400> 6 ttctgatggc tcaaacacag cga 23 <210> 7 <211> 425 <212> DNA <213> Artificial sequence <220> <223> TCRα C region <400> 7 atatccagaa ccctgaccct gccgtgtacc agctgagaga ctctaaatcc agtgacaagt 60 ctgtctgcct attcaccgat tttgattctc aaacaaatgt gtcacaaagt aaggattctg 120 atgtgtatat cacagacaaa tgtgtgctag acatgaggtc tatggacttc aagagcaaca 180 gtgctgtggc ctggagcaac aaatctgact ttgcatgtgc aaacgccttc aacaacagca 240 ttattccaga agacaccttc ttccccagcc cagaaagttc ctgtgatgtc aagctggtcg 300 agaaaagctt tgaaacagat acgaacctaa actttcaaaa cctgtcagtg attgggttcc 360 gaatcctcct cctgaaagtg gccgggttta atctgctcat gacgctgcgg ctgtggtcca 420 gctga 425 <210> 8 <211> 536 <212> DNA <213> Artificial Sequence <220> <223> TCRβ C Region <400> 8 aggacctgaa aaacgtgttc ccacccgagg tcgctgtgtt tgagccatca gaagcagaga 60 tctcccacac ccaaaaggcc acactggtgt gcctggccac aggcttctac cccgaccacg 120 tggagctgag ctggtgggtg aatgggaagg aggtgcacag tggggtcagc acagacccgc 180 agcccctcaa ggagcagccc gccctcaatg actccagata cgctctgagc agccgcctga gggtctcggc caccttctgg caggacccc gcaaccactt ccgctgtcaa gtccagttct 300 acgggctctc ggagaatgac gagtggaccc aggatagggc caaacccgtc acccagatcg tcagcgccga ggcctggggt agagcagact gtggcttcac ctccgagtct taccagcaag 420 gggtcctgtc tgccaccatc ctctatgaga tcttgctagg gaaggccacc ttgtatgccg 480 tgctggtcag tgccctcgtg ctgatggcca tggtcaagag aaaggattcc agaggc 536
Claims
1. A method for amplifying the full-length sequence of a single cell TCR, characterized in that: The following kit was used: The kit comprises a nanoliter microwell chip and a primer pair for amplifying the full-length sequence of TCR; The primer pair for amplifying the full-length sequence of TCR includes an upstream primer and a downstream primer, wherein the upstream primer is a complementary sequence designed according to the sequencing adapter sequence, and the downstream primer is a complementary sequence designed according to the C region of TCR; The nucleotide sequence of the upstream primer is shown in SEQ ID NO.2; The downstream primer is a nested primer; The downstream primers include external primers and internal primers; The full-length TCR consists of the full-length TCRα gene and the full-length TCRβ gene; The nucleotide sequences of the outer primer and the inner primer of the downstream primer for amplifying the full length of the TCRα gene are shown in SEQ ID NO.3 and SEQ ID NO.4, respectively; The nucleotide sequences of the outer primer and the inner primer of the downstream primer for amplifying the full length of the TCRβ gene are shown in SEQ ID NO.5 and SEQ ID NO.6, respectively; The nucleotide sequence of the sequencing adapter sequence is shown in SEQ ID NO.
1.
2. The method according to claim 1, characterized in that The steps include: (1) performing mRNA reverse transcription in the nanoliter microwell chip to obtain a first-strand cDNA; (2) performing PCR amplification using the first-strand cDNA obtained in step (1) as a template; (3) Sequencing verification to obtain the full-length amplification product of the TCR.
3. The method according to claim 2, characterized in that The mRNA reverse transcription system described in step (1) includes a sequencing adapter sequence.
4. The method according to claim 3, characterized in that The final concentration of the sequencing adapter sequence is 0.8-3 μM.
5. The method according to claim 4, characterized in that The final concentration of the sequencing adapter sequence was 2 μM.
6. The method according to claim 2, characterized in that The conditions for mRNA reverse transcription in step (1) are: 38-45°C for 85-95 min for 1-3 cycles; 48-53°C for 1-5 min, 38-45°C for 1-5 min, 8-15 cycles; 68-73°C for 10-20 min for 1-3 cycles; stored at 4°C.
7. The method according to claim 6, characterized in that The conditions for mRNA reverse transcription in step (1) are: 42°C for 90 min for 1 cycle; 50°C for 2 min, 42°C for 2 min, 10 cycles; 70°C for 15 min for 1 cycle; and stored at 4°C.
8. The method according to any one of claims 1 to 7, characterized in that The downstream primer is a nested primer, and the PCR amplification is a nested PCR.
9. The method according to claim 8, characterized in that The nested PCR is performed 1-3 times.
10. The method according to claim 9, characterized in that The nested PCR was performed twice.
11. The method according to claim 10, characterized in that The nested PCR specifically comprises: (1') using the upstream primer and the external primer as primers and the first-strand cDNA as a template, performing a first round of nested PCR to obtain a first round of amplification products; (2') using the upstream primer and the internal primer as primers and the first round amplification product obtained in step (1') as a template, performing a second round of nested PCR to obtain a second round amplification product.
12. The method according to claim 11, characterized in that The conditions of the first round of nested PCR in step (1') are: 92-98°C for 1-6 min, 1-3 cycles; 95-100°C for 15-25 s, 53-58°C for 10-20 s, 70-75°C for 35-45 s, 35-45 cycles; 70-75°C for 3-8 min, 1-3 cycles; stored at 4°C.
13. The method according to claim 12, characterized in that The conditions of the first round of nested PCR in step (1') are: 95°C for 3 min, 1 cycle; 98°C for 20 s, 55°C for 15 s, 72°C for 40 s, 40 cycles; 72°C for 5 min, 1 cycle; and stored at 4°C.
14. The method according to claim 11, characterized in that The conditions of the first round of nested PCR in step (2') are: 92-98°C for 1-6 min, 1-3 cycles; 95-100°C for 15-25 s, 53-58°C for 10-20 s, 70-75°C for 35-45 s, 35-45 cycles; 70-75°C for 3-8 min, 1-3 cycles; stored at 4°C.
15. The method according to claim 14, characterized in that The conditions of the first round of nested PCR in step (2') are: 95°C for 3 min, 1 cycle; 98°C for 20 s, 55°C for 15 s, 72°C for 40 s, 40 cycles; 72°C for 5 min, 1 cycle; and stored at 4°C.
16. The method according to claim 2, characterized in that The sequencing described in step (3) is Sanger sequencing and / or Miseq sequencing.
17. The method according to any one of claims 9 to 16, characterized in that: Prior to step (1), a single cell separation and lysis step is also included.
18. The method according to claim 17, characterized in that The single cells are derived from peripheral blood mononuclear cells.
19. A use of the kit as claimed in claim 1 for the construction of a single-cell TCR library, the kit comprising a nanoliter microwell chip and a primer pair for amplifying the full-length sequence of TCR; The primer pair for amplifying the full-length sequence of TCR includes an upstream primer and a downstream primer, wherein the upstream primer is a complementary sequence designed according to the sequencing adapter sequence, and the downstream primer is a complementary sequence designed according to the C region of TCR; The nucleotide sequence of the upstream primer is shown in SEQ ID NO.2; The downstream primer is a nested primer; The downstream primers include external primers and internal primers; The full-length TCR consists of the full-length TCRα gene and the full-length TCRβ gene; The nucleotide sequences of the outer primer and the inner primer of the downstream primer for amplifying the full length of the TCRα gene are shown in SEQ ID NO.3 and SEQ ID NO.4, respectively; The nucleotide sequences of the outer primer and the inner primer of the downstream primer for amplifying the full length of the TCRβ gene are shown in SEQ ID NO.5 and SEQ ID NO.6, respectively; The nucleotide sequence of the sequencing adapter sequence is shown in SEQ ID NO.1.
